In vitro plasmid-encoded resistance to quinolones

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• Antibiotic resistance is a growing global health concern.
• Quinolones are a critical class of antibiotics used to treat bacterial infections.
• Understanding the genetic basis of quinolone resistance is essential for developing effective treatment strategies.

Purpose of the Study:

• To investigate the potential for plasmid-mediated quinolone resistance.
• To explore the role of the gyrA gene in quinolone resistance.
• To demonstrate a mechanism for the spread of quinolone resistance.

Main Methods:

• Two distinct model systems were employed to study quinolone resistance.
• The impact of wild-type gyrA allele dosage on minimum inhibitory concentrations (MICs) was assessed.
• A mutant gyrA allele was cloned into a multicopy plasmid and expressed in a susceptible Escherichia coli strain.

Main Results:

• Increased levels of the wild-type gyrA allele resulted in a moderate increase in quinolone MICs.
• Expression of the mutant gyrA allele from a multicopy plasmid successfully conferred a quinolone resistance phenotype.
• This indicates that plasmid-borne gyrA mutations can drive resistance.

Conclusions:

• Plasmids can indeed carry and express genes conferring quinolone resistance.
• The gyrA gene is a key target for quinolone action and mutations within it can lead to resistance.
• Plasmid-mediated resistance presents a significant challenge for antibiotic therapy and necessitates further research into resistance mechanisms and control.